Print Page   |   Sign In   |   Join!
Seeing Through the Smoke: Medical Marijuana in Pennsylvania Part II
View Registrations Tell a Friend About This EventTell a Friend

When: 02/28/2017
1:00-2:00 PM
Where: WebEx Webinar
United States
Presenter: Christine Roussel, PharmD, BCOP
Contact: Caroline Santayana
(978) 364-5097

Online registration is closed.
« Go to Upcoming Event List  


Join PSHP Legislative Committee Chair Christine Roussel for part 2 of "Seeing Through the Smoke: Medical Marijuana in Pennsylvania". The pace of change has been swift on this issue and since we last met, the state has released new regulations, applications, and updates on implementation. 


This program is free for PSHP members and $30 for non-members. 

Objectives and Goals for Pharmacists and Pharmacy Technicians

  1. Examine the pathophysiology of Endocannabinoid System and Cannabinoid Pharmacology
  2. Evaluate Clinical Information Available on Chronic Pain and Multiple Sclerosis.
  3. Examine the history of medical cannabis and the legal history in the 20th century.
  4. Describe the regulatory framework Pennsylvania Medical Marijuana Act 16 and the conflict between marijuana’s state and federal status.


Christine Roussel, PharmD, BCOP
Assistant Director of Pharmacy
Doylestown Hospital 

Target Audience

This program is intended for Pharmacists and Pharmacy Technicians.


Amedco is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Successful completion of this program qualifies for up to 1 contact hours.

Full attendance is required. No partial contact hours will be awarded for partial attendance.

0453-9999-17-041-L01-P(K), 0453-9999-17-041-L01-T(K)

 Acknowledgement of Commercial Support

There is no commercial support for this activity. 

Disclosure of Conflict of Interest

The disclosure of information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content of CPE disclosed to Amedco and PSHP. All of these relationships were treated as a conflict of interest and have been resolved. (C7 SCA 6.1-6.2, 6.5)

All individuals in a position to control the content of CPE are listed below.


Commercial Interest


Blia Xiong

Nothing to disclose


Libby Maynard

Nothing to disclose


Christine Roussel

Nothing to disclose



Membership Management Software Powered by YourMembership  ::  Legal